Immutep Limited (IMMP)
$3.63-5.47%Close
SELLCRISIS · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $535M
- Beta
- 2.31
- P/E (TTM)
- -0.58
- Short % float
- 0.03%
- Days to cover
- 2.0
- SI change
- -95.2%
- 1W
- -16.55%
- 1M
- -44.15%
- vs SPY 1W
- -17.71%
- vs SPY 1M
- -47.15%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IMMP?
- LOPJLB’s latest quantitative signal on Immutep Limited (IMMP) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IMMP in?
- Immutep Limited (IMMP) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Immutep Limited (IMMP) do?
- Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includ…